164 related articles for article (PubMed ID: 10998472)
1. Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.
Adlouni A; El Messal M; Saïle R; Parra H; Fruchart J; Ghalim N
Atherosclerosis; 2000 Oct; 152(2):433-40. PubMed ID: 10998472
[TBL] [Abstract][Full Text] [Related]
2. Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition.
McPherson R; Hogue M; Milne RW; Tall AR; Marcel YL
Arterioscler Thromb; 1991; 11(3):476-81. PubMed ID: 1903061
[TBL] [Abstract][Full Text] [Related]
3. [Probucol treatment of hyperlipidemia].
Koizumi J
Nihon Rinsho; 1994 Dec; 52(12):3279-84. PubMed ID: 7853723
[TBL] [Abstract][Full Text] [Related]
4. Decrease of plasma large, light LDL (LDL1), HDL2 and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Sakane H; Ozawa H; Matsuda M; Mikami Y; Mikami Y; Nakamura H
Artery; 1993; 20(1):1-18. PubMed ID: 8447724
[TBL] [Abstract][Full Text] [Related]
5. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
6. The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.
Wilund KR; Colvin PL; Phares D; Goldberg AP; Hagberg JM
Metabolism; 2002 Aug; 51(8):1053-60. PubMed ID: 12145781
[TBL] [Abstract][Full Text] [Related]
7. Selective reduction of cholesterol in HDL2 fraction by probucol in familial hypercholesterolemia and hyperHDL2 cholesterolemia with abnormal cholesteryl ester transfer.
Matsuzawa Y; Yamashita S; Funahashi T; Yamamoto A; Tarui S
Am J Cardiol; 1988 Jul; 62(3):66B-72B. PubMed ID: 3394656
[TBL] [Abstract][Full Text] [Related]
8. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
Inagaki M; Nakagawa-Toyama Y; Nishida M; Nakatani K; Nakaoka H; Kawase M; Kawase R; Tsubakio-Yamamoto K; Masuda D; Ohama T; Matsuyama A; Ishigami M; Komuro I; Yamashita S
J Atheroscler Thromb; 2012; 19(7):643-56. PubMed ID: 22785024
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
[TBL] [Abstract][Full Text] [Related]
11. Effect of probucol on serum lipoprotein and apoprotein profiles in renal transplant patients.
Okubo M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Kumano K; Endo T
Am J Kidney Dis; 1998 Feb; 31(2):356-9. PubMed ID: 9469511
[TBL] [Abstract][Full Text] [Related]
12. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
13. [Separation of high density lipoprotein (HDL) using anti-apo A-I, apo A-II immuno-affinity chromatography to evaluate the effects of probucol].
Kagami A; Hino K; Mochizuki K; Sakamoto T; Tada N; Ishikawa T; Manabe M; Satoh N
Nihon Ronen Igakkai Zasshi; 1991 Nov; 28(6):748-54. PubMed ID: 1795436
[TBL] [Abstract][Full Text] [Related]
14. Modulation of HDL metabolism by probucol in complete cholesteryl ester transfer protein deficiency.
Noto H; Kawamura M; Hashimoto Y; Satoh H; Hara M; Iso-o N; Togo M; Kimura S; Tsukamoto K
Atherosclerosis; 2003 Nov; 171(1):131-6. PubMed ID: 14642415
[TBL] [Abstract][Full Text] [Related]
15. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
Kagami A; Ishikawa T; Tada N; Sakamoto T; Mochizuki K; Nagano M; Moriguchi EH; Manabe M
Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
[TBL] [Abstract][Full Text] [Related]
16. Probucol normalizes cholesteryl ester transfer in IDDM.
Bagdade JD; Stein E; Ritter MC
Diabetes Care; 1995 Oct; 18(10):1341-6. PubMed ID: 8721935
[TBL] [Abstract][Full Text] [Related]
17. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet.
Miida T; Yamaguchi T; Tsuda T; Okada M
Atherosclerosis; 1998 May; 138(1):129-34. PubMed ID: 9678778
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of HDL reduction after probucol. Changes in HDL subfractions and increased reverse cholesteryl ester transfer.
Franceschini G; Sirtori M; Vaccarino V; Gianfranceschi G; Rezzonico L; Chiesa G; Sirtori CR
Arteriosclerosis; 1989; 9(4):462-9. PubMed ID: 2751476
[TBL] [Abstract][Full Text] [Related]
19. In vitro transformation of apoA-I-containing lipoprotein subpopulations: role of lecithin:cholesterol acyltransferase and apoB-containing lipoproteins.
Cheung MC; Wolf AC
J Lipid Res; 1989 Apr; 30(4):499-509. PubMed ID: 2502592
[TBL] [Abstract][Full Text] [Related]
20. Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia.
Homma Y; Kobayashi T; Yamaguchi H; Ozawa H; Sakane H; Nakamura H
Atherosclerosis; 1997 Mar; 129(2):241-8. PubMed ID: 9105567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
